These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Ovarian carcinoma identified by psammoma bodies in the cervicovaginal and endometrial smears. Qizilbash AH Can Med Assoc J; 1974 Jan; 110(2):185-6. PubMed ID: 4810189 [TBL] [Abstract][Full Text] [Related]
9. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum. Prat J; Cancer; 2015 Oct; 121(19):3452-4. PubMed ID: 26110780 [TBL] [Abstract][Full Text] [Related]
10. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin. Bagby C; Ronnett BM; Yemelyanova A; Maleki Z; Kuhn E; Vang R Int J Gynecol Pathol; 2013 Sep; 32(5):433-43. PubMed ID: 23896706 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and significance of psammoma bodies in cervicovaginal smears in a cervical cancer screening program with emphasis on a case of primary bilateral ovarian psammocarcinoma. Pusiol T; Parolari AM; Piscioli I; Morelli L; Del Nonno F; Licci S Cytojournal; 2008 Apr; 5():7. PubMed ID: 18416848 [TBL] [Abstract][Full Text] [Related]
12. Utility of peritoneal washing cytology in staging and prognosis of ovarian and fallopian tube neoplasms: a 10-year retrospective analysis. Davidson W; Madan R; O'Neil M; Tawfik OW; Fan F Ann Diagn Pathol; 2016 Jun; 22():54-7. PubMed ID: 27180061 [TBL] [Abstract][Full Text] [Related]
13. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711 [TBL] [Abstract][Full Text] [Related]
14. Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy. Euscher ED; Silva EG; Deavers MT; Elishaev E; Gershenson DM; Malpica A Am J Surg Pathol; 2004 Sep; 28(9):1217-23. PubMed ID: 15316322 [TBL] [Abstract][Full Text] [Related]
15. Peritoneal serous micropapillomatosis of low malignant potential (serous borderline tumors of the peritoneum). A clinicopathologic study of 17 cases. Biscotti CV; Hart WR Am J Surg Pathol; 1992 May; 16(5):467-75. PubMed ID: 1599025 [TBL] [Abstract][Full Text] [Related]
16. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG). Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932 [TBL] [Abstract][Full Text] [Related]
17. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa? Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429 [TBL] [Abstract][Full Text] [Related]
18. Cancer of the ovary, fallopian tube, and peritoneum. Berek JS; Kehoe ST; Kumar L; Friedlander M Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():59-78. PubMed ID: 30306591 [TBL] [Abstract][Full Text] [Related]